On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...